International Clinical Trial: A Wide-Range Point-of-Care Diagnostic Platform for C-Reactive Protein Based on Spatiotemporal Deep Learning and Smartphone Microfluidics

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129127) titled 'A Wide-Range Point-of-Care Diagnostic Platform for C-Reactive Protein Based on Spatiotemporal Deep Learning and Smartphone Microfluidics' on July 31.

Study Type: Diagnostic test

Study Design: Diagnostic test for accuracy

Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Condition: Systemic inflammatory response, bacterial sepsis, and high-concentration CRP states that may lead to false negatives due to the 'hook effect'

Intervention: Gold Standard:Beckman immunoturbidimetry as the gold standard for detection

Recruitment Status: Not Recruiting

Phase: N/A

Date of First En...